Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129

L. Badimon, E.L. Robinson, A. Jusic, I. Carpusca, L.J. DeWindt, C. Emanueli, P. Ferdinandy, W. Gu, M. Gyongyosi, M. Hackl, K. Karaduzovic-Hadziabdic, M. Lustrek, F. Martelli, E. Nham, I. Potocnjak, V. Satagopam, R. Schneider, T. Thum, Y. Devaux*

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review

Fingerprint

Dive into the research topics of 'Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science